What's new

Orphan designation: Venetoclax Treatment of mantle cell lymphoma, 12/12/2017 Withdrawn

Orphan designation: Venetoclax Treatment of mantle cell lymphoma, 12/12/2017 Withdrawn

Mar 11, 2025 - 13:51
 0
Orphan designation: Venetoclax Treatment of mantle cell lymphoma, 12/12/2017 Withdrawn
Orphan designation: Venetoclax Treatment of mantle cell lymphoma, 12/12/2017 Withdrawn
Read More

Tags:

Previous Article

CrossCountry launches first refurbished Turbostar

Next Article

Orphan designation: Venetoclax Treatment of diffuse large B-cell lymphoma, 14/10...

Related Posts

Regulatory Procedure Management (RPM) for the Product L...

Mar 3, 2025  0

EMEA-000325-PIP01-08-M11

EMEA-000325-PIP01-08-M11

Mar 6, 2025  0

Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation: 14/01/2015, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 10, 2025  0